 | This article has multiple issues. Please help improve it or discuss these issues on the talk page . (Learn how and when to remove these template messages)
|
Tenovus Cancer Care is a Welsh cancer charity that supports cancer patients and their families, funds cancer research, and works to raise awareness on how to prevent cancer.
Tenovus Cancer Care was established in 1943 by ten businessmen (hence the 'ten of us'). Those men were D.R. Edwards, C. Harris, G. Brinn, C.E. Rolfe, D. Curitz, G.T. Addis, T.J.E. Price, H. Thomas, H.E. Gosling and T. Curitz.
Initially, the charity funded a range of local projects in health and social field. In 1964, Tenovus Cancer Care embarked on a project that was to influence their work over the next 40 years. D.R. Edwards, the founder Chairman of the group of ten, cut the first sod on the site of the Tenovus Institute for Cancer Research in Cardiff. Since then, Tenovus Cancer Care has concentrated its efforts on cancer, and Tenovus Cancer Care scientists have been recognised for their pioneering work. [1] [2]
Tenovus Cancer Care remains the biggest Wales-based funder of cancer research and has developed a range of services to support cancer patients directly, including a free Support Line, benefits advice, two Mobile Cancer Support Units and 'Sing with Us' choirs across the country. [1] In 2018, the charity celebrated its 75th anniversary. [3]
The charity has supported scientists whose research has led to significant discoveries benefiting cancer patients globally. For example, in 1975, researchers demonstrated that a contraceptive pill could inhibit the growth of breast cancers, ultimately contributing to the development of Tamoxifen, a medication widely used by millions of women worldwide. [1] [4]
Tenovus Cancer Care allocates approximately £1M annually to fund research endeavors, including both laboratory research aimed at advancing cancer treatments, and community-based research initiatives to support local individuals and their families. [5] Currently, the charity funds PhD studentships in Cardiff, [6] Swansea [7] and Bangor [6] universities.
Tenovus Cancer Care's first Mobile Support Unit was launched in February 2009. Since its launch, the unit has expanded its services to more than 50 locations, providing support to numerous patients and visitors. Working with Velindre NHS Trust, Tenovus Cancer Care has been delivering chemotherapy and other cancer treatments in Cwmbran and Nantgarw. During this period, the Mobile Support Unit has provided over 10,000 treatments.
In October 2013, a second Mobile Support Unit was launched to deliver support for people with lymphoedema, an incurable condition that can be a side-effect of cancer treatment. [8] In October 2018, the new £1 million Mobile Support Unit was unveiled by HRH The Princess Royal. It is notably sized, with seven chemotherapy chairs, capable of accommodating 30 patients daily and delivering over 8,500 treatments annually. Calculations suggest that the collective impact of the existing Mobile Support Units saves the NHS in Wales more than £1 million annually, and the new Mobile Support Unit could deliver more than 125,000 treatments over its operational lifespan. [9]
In 2014, Tenovus Cancer Care collaborated with Movember and Prostate Cancer UK to launch the UK's first ManVan, a 38-foot American Motorhome that offers men a safe, relaxing space in which to discuss issues around male cancers such as prostate and testicular cancer. [10] During the three-year project, the ManVan had more than 6,200 visitors, helped over 600 men who had a cancer diagnosis and offered around 4,000 appointments. It visited almost 100 locations across the country and travelled over 42,326 miles.
Tenovus Cancer Care also has a 14-strong team of Cancer Support Advisors, offering help, guidance and support through its multi-disciplinary service, allowing patients and their families to access a number of services directly through the charity. The team provides advice about welfare benefits for cancer patients and helps people apply for grants, blue badges and other essential support. [11]
Tenovus Cancer Care has a national free Support Line (0808 808 1010), which is open 8am-8pm, 365 days a year. They more recently launched a proactive telephone chemotherapy callback service (Tenovus Cancer Care Callback) where a Tenovus Cancer Care Nurse Specialist contacts cancer patients throughout their treatment to provide advice and support. [12]
In 2012, Tenovus Cancer Care launched the 'Sing with Us' project, funded by the Big Lottery, to run 15 choirs across Wales for cancer patients, survivors, their families and people bereaved through cancer. Initial research conducted by Cardiff University and Tenovus Cancer Care has proved that singing in the choirs reduces anxiety and pain, as well as helping to improve physical function. Tenovus Cancer Care's work in this area also featured in the October 2012 Channel 4 documentary 'Sing For Your Life', where the charity set up a choir of cancer patients that performed at the Royal Albert Hall. [13] [14]
In late 2014, Tenovus Cancer Care set up their first Sing with Us choir outside Wales, in Guildford, Surrey. In 2015, Tenovus Cancer Care conducted research with the Royal College of Music in London into the benefits of singing. By taking saliva samples from around 200 choir members before, and after rehearsal, they showed singing in one of their choirs was effective at reducing peoples' anxiety and depression, and had a positive impact on biological markers related to stress, immune function and inflammatory response. This research is now being expanded on with a two-year study with the Royal College of Music and the Royal Marsden Hospital. [15]
Cancer Research UK (CRUK) is the world's largest independent cancer research organisation. It is registered as a charity in the United Kingdom and Isle of Man, and was formed on 4 February 2002 by the merger of The Cancer Research Campaign and the Imperial Cancer Research Fund. Cancer Research UK conducts research using both its own staff and grant-funded researchers. It also provides information about cancer and runs campaigns aimed at raising awareness and influencing public policy.
The Leukemia & Lymphoma Society (LLS), a 501(c)(3) charitable organization founded in 1949, is a voluntary health organization dedicated to fighting blood cancer world-wide. LLS funds blood cancer research on cures for leukemia, lymphoma, Hodgkin's disease, and myeloma. It provides free information and support services, and it advocates for blood cancer patients and their families seeking access to quality and affordable care.
Diabetes UK is a British-based patient, healthcare professional and research charity that has been described as "one of the foremost diabetes charities in the UK". The charity campaigns for improvements in the care and treatment of people with diabetes.
Marie Curie is a registered charitable organisation in the United Kingdom which provides hospice care and support for anyone with an illness they’re likely to die from, and those close to them, and campaigns for better support for dying people. It was established in 1948, the same year as the National Health Service (NHS).
The Brain Tumour Charity is a UK-based, Charity Commission registered, charity dedicated to funding research, raising awareness of brain tumours, reducing diagnosis times and providing support and information for people with brain tumours, their families and friends.
Dana-Farber Cancer Institute is a comprehensive cancer treatment and research institution in Boston, Massachusetts. Dana-Farber is the founding member of the Dana-Farber/Harvard Cancer Center, Harvard's Comprehensive Cancer Center designated by the National Cancer Institute, and one of the 15 clinical affiliates and research institutes of Harvard Medical School.
King George Hospital is an NHS hospital located on Barley Lane in the Goodmayes area of Ilford, in the London Borough of Redbridge. The hospital is part of Barking, Havering and Redbridge University Hospitals NHS Trust.
The National Cancer Research Institute (NCRI) is a UK-wide partnership between cancer research funders, which promotes collaboration in cancer research. Its member organizations work together to maximize the value and benefit of cancer research for the benefit of patients and the public. Rather than replace or duplicate any of the functions of its members, it seeks to add value through joint planning, coordination and collaboration.
John Gordon McVie was an international authority on the treatment and research of cancer. He wrote over 350 peer-reviewed articles, editorials and books. McVie was born in Glasgow, Scotland and died of non-Hodgkin lymphona and COVID-19 in Bristol, England.
Breast Cancer Care is the only specialist UK-wide charity in the UK providing care, support and information to anyone affected by breast cancer. The charity's headquarters are in London, with additional offices in Sheffield, Cardiff, and Glasgow. It is regularly quoted by media looking for the perspective of patients on breast cancer.
World Lymphoma Awareness Day (WLAD) is held on September 15 every year and is a day dedicated to raising awareness of lymphoma, an increasingly common form of cancer. It is a global initiative hosted by the Lymphoma Coalition (LC), a non-profit network organisation of 83 lymphoma patient groups from 52 countries around the world. WLAD was initiated in 2004 to raise public awareness of both Hodgkin and non-Hodgkin lymphoma in terms of symptom recognition, early diagnosis and treatment.
The INCTR Challenge Fund is the UK charity (Charity No. 1079181) raising funds for projects co-ordinated by the International Network for Cancer Treatment Research (INCTR) that improve the care delivered to cancer patients in developing countries and help reduce their suffering.
The Sir Bobby Robson Foundation is a British cancer research charity which raises money to fund the early detection and treatment of cancer, and clinical trials of anti-cancer drugs. Based in the North East of England, the Foundation was launched on 25 March 2008 in the name of Sir Bobby Robson, himself a cancer sufferer five times since 1992, and who died of the disease on 31 July 2009.
The King Hussein Cancer Foundation (KHCF) and Center (KHCC) ,an independent Jordanian non-governmental, non-profit institution. It was established in 2001 by a royal decree issued and is led by Princess Ghida Talal. The Foundation's mission is to combat cancer through awareness, prevention, and early detection programs, providing comprehensive care for cancer patients from Jordan and the Arab world, in addition to promoting research and innovation.
The Royal Osteoporosis Society (ROS), formerly the National Osteoporosis Society, established in 1986, is the only UK-wide charity dedicated to improving the prevention, diagnosis and treatment of osteoporosis. It is based in Camerton, Somerset, England.
Sing Up is a music education organisation in England that provides schools and teachers with online resources for singing and music-making activities. Its headquarters are located in Gateshead.
Genetic Alliance UK is a national charity and an alliance of over 200 patient organisations, supporting those affected by genetic conditions. Genetic Alliance UK's aim is to improve the lives of people affected by genetic conditions, ensuring that high quality services and information are available to all who need them.
The Clatterbridge Cancer Centre is an NHS Foundation Trust, which specialises in the treatment of cancer. The centre is one of several specialist hospitals located within Merseyside; alongside Liverpool Heart and Chest Hospital, Alder Hey Children's Hospital, Liverpool Women's Hospital, and the Walton Centre.
The Medical Technology Group (MTG) is a not for profit organisation in the United Kingdom comprising patient groups, research charities and medical device manufacturers. Its stated aim is to "work together to improve patient access to effective medical technologies". The Group launched in 2001.
The UK Coronavirus Cancer Programme or UKCCP is one of the longest running UK pandemic research programmes to safeguard, monitor and protect individuals living with cancer from COVID-19 across the United Kingdom.
